Cas:951884-19-8 2-Bromo-N-butyl-5-fluorobenzamide manufacturer & supplier

Chemical Name:2-Bromo-N-butyl-5-fluorobenzamide

CAS.NO:951884-19-8

Synonyms:PC7976;N-Butyl 2-bromo-5-fluorobenzamide

Molecular Formula:C₁₁H₁₃BrFNO

Molecular Weight:274.12900

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.10000

Exact Mass:273.01600

LogP:3.50900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like PC7976 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Butyl 2-bromo-5-fluorobenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Butyl 2-bromo-5-fluorobenzamide Use and application,N-Butyl 2-bromo-5-fluorobenzamide technical grade,usp/ep/jp grade.

Related News: There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 2-Bromo-N-butyl-5-fluorobenzamide manufacturer Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 2-Bromo-N-butyl-5-fluorobenzamide supplier The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. 2-Bromo-N-butyl-5-fluorobenzamide vendor There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 2-Bromo-N-butyl-5-fluorobenzamide factory The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood.